USE OF EPIDERMAL GROWTH FACTOR FOR THE MORPHOFUNCTIONAL RESTORATION OF PERIPHERAL NERVES IN DIABETIC NEUROPATHY

The present invention is relevant to human medicine, and, in particular, to the use of Epidermal Growth Factor (EGF) in a pharmaceutical composition, said composition is administered through infiltration at the periphery of nerve trunks and/or ganglia, for the morphofunctional restoration of periphe...

Full description

Saved in:
Bibliographic Details
Main Authors HERRERA MARTINEZ LUIS SATURNINO, CIBRIAN VERA DANAY, SAEZ MARTINEZ VIVIAN MARIA, FERNANDEZ MONTEQUIN JOSE IGNACIO, UBIETA GOMEZ RAIMUNDO, GONZALEZ BLANCO SONIA, BERLANGA ACOSTA JORGE AMADOR, GUILLEN NIETO GERARDO ENRIQUE, GARCIA DEL BARCO HERRERA DIANA
Format Patent
LanguageEnglish
Published 17.04.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention is relevant to human medicine, and, in particular, to the use of Epidermal Growth Factor (EGF) in a pharmaceutical composition, said composition is administered through infiltration at the periphery of nerve trunks and/or ganglia, for the morphofunctional restoration of peripheral nerves in painful, sensitive-motor neuropathy, as well as ischemic neuritis. It is also relevant to an EGF containing composition, where this molecule can be formulated together with anesthetic or analgesic drugs, or encapsulated in microspheres, and their use for the morphofunctional restoration of peripheral nerves in painful, sensitive-motor neuropathy, as well as in ischemic neuritis.
Bibliography:Application Number: US201314140849